A risk stratification model for coronary artery lesions in Kawasaki disease: focus on subgroup-specific utility.

IF 2.8 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Frontiers in Cardiovascular Medicine Pub Date : 2025-04-29 eCollection Date: 2025-01-01 DOI:10.3389/fcvm.2025.1543767
Chuxiong Gong, Zhongjian Su, Qinhong Li, Hongyan Li, Ziyu Wang, Huiing Gao, Yamin Li, Xiaomei Liu, Lili Deng
{"title":"A risk stratification model for coronary artery lesions in Kawasaki disease: focus on subgroup-specific utility.","authors":"Chuxiong Gong, Zhongjian Su, Qinhong Li, Hongyan Li, Ziyu Wang, Huiing Gao, Yamin Li, Xiaomei Liu, Lili Deng","doi":"10.3389/fcvm.2025.1543767","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Kawasaki disease is an acute immune vasculitis that often has a poor prognosis when complicated by coronary artery lesions. Our study aims to construct a risk model for Kawasaki disease complicated by coronary artery lesions and validate it in different clinical characteristic subgroups, optimizing personalized and precise management of Kawasaki disease to improve patient outcomes.</p><p><strong>Methods: </strong>First, we compared each factor between the groups with and without coronary artery damage. We then used LASSO analysis to further filter for factors that were more significant in predicting outcomes. The selected factors were used to construct the risk model. The model was evaluated using ROC curves, calibration curves, and DCA, and was internally validated using 5-fold cross-validation. Finally, we also conducted subgroup analyses based on factors such as age stages and sex.</p><p><strong>Results: </strong>Through univariate analysis, LASSO analysis, and correlation analysis, we identified WBC, PLT, CRP, ALB, Na, Time to IVIG treatment, and symptoms of limb as the key factors for constructing the risk model. The model achieved an area under the curve of 0.815(95%CI: 0.779-0.851). Additionally, calibration curves, DCA, and 10-fold cross-validation demonstrated that the model has good predictive performance. The predictive efficacy of the model was also satisfactory across various subgroups.</p><p><strong>Conclusions: </strong>Our study has constructed a risk model for Kawasaki disease complicated by coronary artery lesions in the Chinese population that demonstrates good predictive performance, and it has been validated successfully across multiple subgroups.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1543767"},"PeriodicalIF":2.8000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069354/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1543767","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Kawasaki disease is an acute immune vasculitis that often has a poor prognosis when complicated by coronary artery lesions. Our study aims to construct a risk model for Kawasaki disease complicated by coronary artery lesions and validate it in different clinical characteristic subgroups, optimizing personalized and precise management of Kawasaki disease to improve patient outcomes.

Methods: First, we compared each factor between the groups with and without coronary artery damage. We then used LASSO analysis to further filter for factors that were more significant in predicting outcomes. The selected factors were used to construct the risk model. The model was evaluated using ROC curves, calibration curves, and DCA, and was internally validated using 5-fold cross-validation. Finally, we also conducted subgroup analyses based on factors such as age stages and sex.

Results: Through univariate analysis, LASSO analysis, and correlation analysis, we identified WBC, PLT, CRP, ALB, Na, Time to IVIG treatment, and symptoms of limb as the key factors for constructing the risk model. The model achieved an area under the curve of 0.815(95%CI: 0.779-0.851). Additionally, calibration curves, DCA, and 10-fold cross-validation demonstrated that the model has good predictive performance. The predictive efficacy of the model was also satisfactory across various subgroups.

Conclusions: Our study has constructed a risk model for Kawasaki disease complicated by coronary artery lesions in the Chinese population that demonstrates good predictive performance, and it has been validated successfully across multiple subgroups.

川崎病冠状动脉病变的风险分层模型:关注亚组特异性效用
目的:川崎病是一种急性免疫性血管炎,合并冠状动脉病变预后较差。本研究旨在构建川崎病合并冠状动脉病变的风险模型,并在不同临床特征亚组中进行验证,优化川崎病的个性化精准治疗,改善患者预后。方法:首先比较冠状动脉损伤组和非冠状动脉损伤组各因素的差异。然后,我们使用LASSO分析进一步过滤在预测结果中更重要的因素。选取的因素用于构建风险模型。采用ROC曲线、校准曲线和DCA对模型进行评价,并采用5倍交叉验证进行内部验证。最后,我们还根据年龄阶段和性别等因素进行了亚组分析。结果:通过单因素分析、LASSO分析和相关分析,我们确定WBC、PLT、CRP、ALB、Na、IVIG治疗时间和肢体症状是构建风险模型的关键因素。模型的曲线下面积为0.815(95%CI: 0.779-0.851)。此外,校准曲线、DCA和10倍交叉验证表明该模型具有良好的预测性能。该模型在各个亚组的预测效果也令人满意。结论:本研究构建了中国人群川崎病合并冠状动脉病变的风险模型,该模型具有良好的预测性能,并已在多个亚组中成功验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.80
自引率
11.10%
发文量
3529
审稿时长
14 weeks
期刊介绍: Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers? At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信